MedPath

OCEANSIDE PHARMACEUTICALS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

61

FDA:61

Drug Approvals

Diazepam

Approval Date
Jan 4, 2024
FDA

Azathioprine

Approval Date
Dec 18, 2023
FDA

HYDROCORTISONE BUTYRATE

Approval Date
Dec 11, 2023
FDA

mesalamine

Approval Date
Oct 31, 2023
FDA

Tretinoin

Approval Date
Oct 30, 2023
FDA

Omeprazole and Sodium Bicarbonate

Approval Date
Oct 11, 2023
FDA

ethacrynic sodium

Approval Date
Aug 31, 2023
FDA

PEG-3350, Electrolytes, and Ascorbate

Approval Date
Jun 1, 2023
FDA

Clindamycin Phosphate and Benzoyl Peroxide

Approval Date
Jan 1, 2023
FDA

Metronidazole

Approval Date
Jun 21, 2022
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.